# Novartis AG: Form 6-K, filed Mar 18, 2026

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2026-03-18
- Accepted by EDGAR: Mar 18, 2026, 16:23 ET
- Period: 2026-03-18
- Accession: 0001104659-26-031037
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000110465926031037/tm268725d5_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000110465926031037/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000110465926031037/tm268725d5_6k.htm

Filed Mar 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-031037. Last ingested by Listed: Nov 11, 2026, 02:03 ET. No prices; not investment advice.